Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.88 Analyst target: $7.00 Upside: 80.41%
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company is headquartered in Marietta, Georgia.
See the full interactive analysis & chart →Informational only — not investment advice.